Company / SG&A Expense
ZEVRA THERAPEUTICS, INC. SG&A Expense History
FY2015-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$1.4M
FY2015
5-year range
$1.4M / $1.4M
FY2015-FY2015
Trend
-
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$1M in FY2015.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.20 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $1.4M | - |
As of FY2015 · SEC 10-K · Updated Jun 28, 2026